VOYA Investment Management
ACET icon

VOYA Investment Management’s Adicet Bio ACET Stock Holding History

VOYA Investment Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,267
Closed -$47.6K – 2824
2024
Q1 		$47.6K Buy
+1,267
New +$52.4K ﹤0.01% 2733
2023
Q3 		– Sell
-772
Closed -$30K – 2897
2023
Q2 		$30K Sell
772
-3,391
-81% -$299K ﹤0.01% 2916
2023
Q1 		$384K Sell
4,163
-3,429
-45% -$430K ﹤0.01% 2190
2022
Q4 		$1.09M Hold
7,592
– – ﹤0.01% 1591
2022
Q3 		$1.73M Buy
7,592
+6,921
+1,031% +$1.76M ﹤0.01% 1378
2022
Q2 		$157K Buy
+671
New +$147K ﹤0.01% 2486

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

VOYA Investment Management's ACET Position: Q2 2024 in Review

VOYA Investment Management sold out of Adicet Bio (ACET) in Q2 2024, closing a stake of 1,267 shares — an estimated $47.6K sold.

VOYA Investment Management first reported a position in ACET in Q2 2022 and held it in 6 quarters. The position peaked at $1.73M in Q3 2022. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • VOYA Investment Management reported no remaining Adicet Bio position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 1,267 Adicet Bio shares in Q2 2024, an estimated $47.6K.
  • VOYA Investment Management first reported a position in Adicet Bio in Q2 2022 and held it in 6 quarters.
  • VOYA Investment Management's Adicet Bio position peaked at $1.73M in Q3 2022.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.